BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
England and Wales Court of Protection Decisions |
||
You are here: BAILII >> Databases >> England and Wales Court of Protection Decisions >> Sherwood Forest Hospitals NHS Foundation Trust v C [2020] EWCOP 10 (27 February 2020) URL: http://www.bailii.org/ew/cases/EWCOP/2020/10.html Cite as: [2020] EWCOP 10, [2020] COPLR 696 |
[New search] [Printable PDF version] [Help]
Strand, London, WC2A 2LL |
||
B e f o r e :
VICE PRESIDENT OF THE COURT OF PROTECTION
____________________
Sherwood Forest Hospitals NHS Foundation Trust |
Applicant |
|
- and - |
||
C (by her litigation friend the Official Solicitor) Nottinghamshire Healthcare NHS Foundation Trust |
Respondents |
____________________
Ms Fiona Paterson (instructed by Official Solicitor) for the Respondent
Hearing dates: 28th February 2020
____________________
Crown Copyright ©
Mr Justice Hayden :
C's mental health history
Circumstances of C's recent presentation
"24. Treatment should ideally take place within the next month but at the latest be performed within 3 months. Without treatment it is likely that the cancer will progress causing metastatic disease throughout the abdomen and chest and symptoms such as pain, bleeding shortness of breath and ultimately death. It is difficult to estimate how quickly CC's cancer will progress if left untreated because for obvious reasons there are no clinical trials which cover this.
25.The exact timescale of progression is difficult to estimate but anecodotal evidence suggests that it is likely to progress from early stage to advanced cancer in an untreated patient within around 5 years. The stage of CC's cancer will be determined following histopathological analysis of the hysterectomy specimen following surgery.